NVNO
USDenVVeno Medical Corporation Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$2.766
고가
$2.766
저가
$2.660
거래량
0.00M
기업 기본 정보
시가총액
48.0M
산업
의료 기기
국가
United States
거래 통계
평균 거래량
0.09M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand
- Access video webcasts from the first wave of participating companies hereFRENCHTOWN, NJ / ACCESS Newswire / February 19, 2025 / JTC Team , a fully integrated corporate communications and investor
One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum
One-year follow-up data demonstrates sustained improvements across venous specific quality-of-life indicators.PMA application for the VenoValve submitted in November 2024, with an FDA decision expected in the
Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting
Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.78% of subjects maintained a clinically meaningful
